Carboplatin Treatment Options

A collection of 1685 research studies where Carboplatin is the interventional treatment. These studies are located in the United States . Carboplatin is used for conditions such as Non-Small Cell Lung Cancer, Ovarian Cancer and Lung Cancer.

Home

All Treatments

Carboplatin

Show Filters

Match to Clinical Trials

Access to cutting-edge treatments

Latest clinical trials

Find trials in your area

Start Matching

Filter by Age

Featured Trial

Healthy Participants Needed (Colonoscopy + Cancer Screening)

Recruiting

Earn $325 - $475 in electronic payment card compensation for your time and effort by participating in a clinical study to develop a blood test that may one day help screen for colon cancer. Take a quick quiz to see if you qualify.

Conditions:

Healthy

Healthy Volunteers

Healthy Subjects

Healthy Volunteer

Healthy Participants

Learn More

Featured Trial

Buy Retatrutide Online Through Celia

Recruiting

Retatrutide (formerly M25) is an investigational peptide being studied for its potential in supporting weight management and metabolic health. It acts on GLP-1, GIP, and glucagon receptors to influence appetite, energy regulation, and fat metabolism.

Conditions:

Healthy

Learn More

Featured Offer

Lose 20% of Body Weight With GLP-1's

Policy Lab has partnered with OnlineSemaglutide.org to offer trusted access to tirzepatide and other GLP-1 medications, including generic alternatives to Ozempic® and Wegovy®.

Semaglutide and Tirzepatide are advanced GLP-1 medications designed to support weight management and metabolic health. They work by targeting GLP-1 receptors in the body, helping regulate appetite, improve blood sugar control, and support sustainable weight loss (up to 22% of body weight).

Get $50 off your first order using promo code: policy-lab-50

Conditions:

Overweight

Overweight and Obesity

Obesity

Weight Loss

Morbid Obesity

Learn More

Featured Trial

Birth Control Clinical Research Study

Recruiting

Living with obesity and looking for a birth control option that is right for you? Clinical trials are now enrolling women with a body mass index (BMI) of 30 or more in the area to help study a potential new progestin-only contraceptive patch. Participating in research studies can help advance birth control options. Don’t let financial stress hold you back. All study-related assessments, care, and study patch are available at no cost. You may also be reimbursed for study-related travel.

Conditions:

Obesity

Overweight

Overweight and Obesity

Learn More

Trilaciclib, a CDK 4/6 Inhibitor, in Patients Receiving Gemcitabine and Carboplatin for Metastatic Triple-Negative Breast Cancer (TNBC)

NCT04799249

Completed

This is a Phase 3, multicenter, randomized, double-blind, placebo-controlled study evaluating the safety and efficacy of trilaciclib versus placebo administered prior to gemcitabine and carboplatin in patients receiving first- or second-line treatment for locally advanced unresectable/metastatic TNBC.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

07/31/2024

Locations: Banner M.D. Anderson Cancer Center, Gilbert, Arizona +70 locations

Banner M.D. Anderson Cancer Center, Gilbert, Arizona

Washington Cancer Institute at MedStar Washington Hospital Center - Oncology Research, Washington, District of Columbia

Florida Cancer Specialists - North (SCRI), Saint Petersburg, Florida

Moffitt Cancer Center, Tampa, Florida

Maryland Oncology Hematology, P.A., Clinton, Maryland

Saint Luke's Cancer Specialists, Kansas City, Missouri

Comprehensive Cancer Genetics of Nevada, Las Vegas, Nevada

Duke Cancer Center, Durham, North Carolina

UPC Pinnacle Health Cancer Institute, Pittsburgh, Pennsylvania

Tennessee Oncology Chattanooga, Chattanooga, Tennessee

Baptist Cancer Cancer - Oncology, Memphis, Tennessee

Tennessee Oncology (SCRI), Nashville, Tennessee

Texas Oncology- Austin Central, Austin, Texas

Texas Oncology - Baylor Charles A. Sammons Cancer Center, Dallas, Texas

Texas Oncology P.A., Tyler, Texas

Virginia Oncology Associates, Norfolk, Virginia

Chris O'Brien Lifehouse, Camperdown, New South Wales

Sunshine Coast University Hospital, Birtinya, Queensland

Peter MacCallum Cancer Centre - Oncology, East Melbourne, Victoria

Cabrini Health, Malvern, Victoria

Mater Hospital Sydney, North Sydney, Not set

Complex Oncology Center - Burgas, Burgas, Not set

Medical Ctr Nadezhda Clinical, Sofia, Not set

Cancer Hospital Chinese Academy of Medical Sciences, Chaoyang, Beijing

The First Affiliated Hospital of Chongqing Medical University, Yuzhong, Chongqing

Sun Yat-sen University Cancer Center, Yuexiu, Guangzhou

The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei

Anhui Provincial Hospital, Harbin, Heilongjiang

First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan

Jilin Cancer Hospital, Changchun, Jilin

The First Hospital of Jilin University, Changchun, Jilin

Tianjin Cancer Hospital, Tianjin, Tianjin

Zhejiang Cancer Hospital, Hangzhou, Zhejiang

Fudan University Shanghai Cancer Center, Shanghai, Not set

Centre Jean Bernard, Le Mans, Europe

Centre Francois Baclesse, Caen, Not set

ICM-Val d'Aurelle, Montpellier, Not set

Centre Hospitalier de Poitiers, Poitiers, Not set

Pharmacie Essais Cliniques, Toulouse, Not set

Centre Leon Berard, Villejuif, Not set

High Technology Hospital MedCenter LTD, Batumi, Ajaria

Acad.Fridon Todua Medical Center - Research Institute of Clinical Medicine, Tbilisi, Not set

ARENSIA Exploratory Medicine Harmony Health, Tbilisi, Not set

LTD Israeli-Georgian Medical Research Clinic Helsicore, Tbilisi, Not set

LTD Multiprofile Clinic Consilium Medulla, Tbilisi, Not set

TIM - Tbilisi Institute of Medicine LTD, Tbilisi, Not set

Institute Of Clinical Oncology LTD, Tbilisi, Not set

IMSP Institutul Oncologic, ARENSIA Exploratory Medicine, Chisinau, Not set

Pratia MCM Krakow, Krakow, Malopolskie

Med-Polonia Sp. Z o.o., Poznan, Wielkopolskie

Wojewodzkie Wielospecjalistyczne Centrum Onkologii i Traumatologii im. M. Kopernika w Lodzi, Oddzial Chorob Rozrostowych, Lodz, Not set

Centrum Medyczne Pratia Poznan, Skorzewo, Not set

Narodowy Instytut Onkologii im. Marii Sklodowskiej - Curie - Panstwowy Instytut Badawczy, Warszawa, Not set

Instytut MSF Sp. z. o.o., Łódź, Not set

Saint-Petersburg State Budgetary Healthcare Institution "City Clinical Oncology Dispensary", Moscow, Balashikha

SAHI Republcx Clinical Oncology Dispensary of the Ministry of Healthcare of Tatarstan Republix, Kazan, Not set

FSBI Russian Scientific Center of Roentgenoradiology of the MoH of Russia, Moscow, Not set

State Budgetary Healthcare Institution of Moscow Region "Moscow Reginoal Oncology Dispensary", Moscow, Not set

Budgetary Healthcare Institution of Omsk Region "Clinical Oncological Dispensary", Omsk, Not set

Hospital General Universitario de Elche, Elche, Alicante

Hospital Puerta de Hierro Majadahonda, Madrid, Majadahonda

Hospital Universitario de Badajos, Badajoz, Not set

Hospital Universitario 12 de Octubre, Barcelona, Not set

Vall d'Hebrón University Hospital, Barcelona, Not set

Hospital Clìnic de Barcelona, Barcelona, Not set

Hospital Universitario Ramón y Cajal, Madrid, Not set

Yuri Prokopovich Spizhenko, Kapitanivka, Kyivska Oblast

Komunalne nekomertsiine pidpryiemstvo Sumskoi oblasnoi rady Sumskyi oblasnyi onkolohichnyi dyspanser, Sumy, Sums'ka Oblast

Komunalne nekomertsiine pidpryiemstvo Ternopilskyi oblasnyi klinichnyi onkolohichnyi dyspanser Ternopilskoi oblasnoi rady, Ternopil, Ternopil's'ka Oblast

Volynskyi oblasnyi medychnyi tsentr onkolohii, Lutsk, Volyns'ka Oblast

Komunalne nekomertsiine pidpryiemstvo Miska klinichna likarnia No 4 Dniprovskoi miskoi rady, Dnipro, Not set

Conditions: TNBC - Triple-Negative Breast Cancer, Breast Cancer

Learn More ›

SGI-110 in Combination With Carboplatin in Ovarian Cancer

NCT01696032

Completed

A 2-part, Phase 2 controlled, open-label, randomized study in participants with platinum-resistant recurrent ovarian cancer. In Part 1, participants received SGI-110 and carboplatin. The optimum dose of SGI-110 (guadecitabine) was identified in Part 1 based on safety and efficacy. In Part 2, participants were randomized to receive the dose identified in Part 1 plus carboplatin or one of four treatment of choice at the discretion of the investigator. The treatment of choice consisted of topotecan... Read More

Gender:

FEMALE

Ages:

18 years and above

Trial Updated:

07/31/2024

Locations: Norris Comprehensive Cancer Center- University of Southern California, Los Angeles, California +23 locations

Norris Comprehensive Cancer Center- University of Southern California, Los Angeles, California

University of Florida Shands Cancer Center, Gainesville, Florida

Georgia Health Sciences University, Augusta, Georgia

University of Chicago, Chicago, Illinois

Melvin and Bren Simon Cancer Center- Indiana University, Indianapolis, Indiana

Women's Cancer Care, Covington, Louisiana

Johns Hopkins Kimmel Cancer Center, Baltimore, Maryland

Dana Farber Cancer Institute, Boston, Massachusetts

Island Gynecologic Oncology, Brightwaters, New York

Duke Cancer Institute- Duke University Medical Center, Durham, North Carolina

University of Cincinnati Cancer Institute, Cincinnati, Ohio

Mary Crowley Medical Research Center, Dallas, Texas

Inova Fairfax Hospital, Falls Church, Virginia

Tom Baker Cancer Centre, Calgary, Alberta

Juravinski Cancer Centre, Hamilton, Ontario

Princess Margaret Hospital, Toronto, Ontario

CHUM Gynecologie-Oncologie, Notre Dame Hospital, Montreal, Quebec

Bristol Heamatology and Oncology Centre, Bristol, Not set

St. James Univesity Hospital - St. James Institute of Oncology, Leeds, Not set

Cambridge University Hospitals NHS Foundation and Trust, London, Not set

Univesity College Hospital, London, Not set

Imperial College Health Care NHS Trust-Garry Weston Centre, London, Not set

Mount Vernon Cancer Centre, Middlesex, Not set

Royal Marsden Foundation Trust, Sutton, Not set

Conditions: Ovarian Cancer

Learn More ›

Pharmacological Ascorbate for Lung Cancer

NCT02420314

Completed

This clinical trial evaluates adding high-dose ascorbate (vitamin C) to standard of care treatment of non-small cell lung cancer (NSCLC) in adults. All subjects will receive high-dose ascorbate in addition to the standard treatment.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

07/30/2024

Locations: Holden Comprehensive Cancer Center, Iowa City, Iowa

Conditions: Carcinoma, Non-Small-Cell Lung

Learn More ›

Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Carboplatin Followed By Chemoradiation in Treating Patients With Recurrent Head and Neck Cancer

NCT01847326

Completed

This phase I trial studies the side effects and best dose of paclitaxel albumin-stabilized nanoparticle formulation when given together with carboplatin followed by chemoradiation in treating patients with recurrent head and neck cancer. Drugs used in chemotherapy, such as paclitaxel albumin-stabilized nanoparticle formulation, carboplatin, fluorouracil, and hydroxyurea, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Radia... Read More

Gender:

ALL

Ages:

18 years and above

Trial Updated:

07/29/2024

Locations: University of Chicago Comprehensive Cancer Center, Chicago, Illinois

Conditions: Recurrent Salivary Gland Cancer, Recurrent Squamous Cell Carcinoma of the Hypopharynx, Recurrent Squamous Cell Carcinoma of the Larynx, Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity, Recurrent Squamous Cell Carcinoma of the Nasopharynx, Recurrent Squamous Cell Carcinoma of the Oropharynx, Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Recurrent Verrucous Carcinoma of the Larynx, Recurrent Verrucous Carcinoma of the Oral Cavity, Salivary Gland Squamous Cell Carcinoma, Tongue Cancer

Learn More ›

Biomarkers of Response to Pembrolizumab Combined With Chemotherapy in Non-Small Cell Lung Cancer (KEYNOTE-782, MK-3475-782)

NCT03664024

Completed

Participants with Stage IV nonsquamous non-small cell lung cancer (NSCLC) without prior systemic treatment will be treated with standard of care pembrolizumab combined with platinum-doublet chemotherapy for 4 cycles, then pembrolizumab plus pemetrexed maintenance for up to 31 additional cycles. The platinum doublet would be pemetrexed plus the investigator's choice of either cisplatin or carboplatin. The primary objective is to evaluate if total baseline tumor mutation burden (TMB) in cell-free... Read More

Gender:

ALL

Ages:

18 years and above

Trial Updated:

07/29/2024

Locations: University Of Colorado ( Site 0908), Aurora, Colorado +14 locations

Conditions: Non-Small Cell Lung Cancer

Learn More ›

Avelumab With Chemoradiation for Stage II/III Resectable Esophageal and Gastroesophageal Cancer

NCT03490292

Completed

This is a 2 part Phase I/II clinical trial evaluating the safety, tolerability and efficacy of avelumab in combination with chemoradiation in patients with resectable esophageal and gastroesophageal cancer. Part 1: This is the run-in phase of the trial. This portion will determine the safety and tolerability of avelumab in combination with chemoradiotherapy in 6 patients. The proposed combination will be considered as safe if dose limiting toxicities are observed in at most 1 patient. Part 2:... Read More

Gender:

ALL

Ages:

18 years and above

Trial Updated:

07/25/2024

Locations: University of Wisconsin Carbone Cancer Center, Madison, Wisconsin

Conditions: Resectable Esophageal Cancer, GastroEsophageal Cancer

Learn More ›

Trial of Cisplatin Plus Radiation Followed by Carbo and Taxol Vs. Sandwich Therapy of Carbo and Taxol Followed Radiation Then Further Carbo and Taxol

NCT02501954

Completed

To determine if treatment with cisplatin and radiation followed by carbo and taxol reduces the rate of recurrence when compared to sandwich therapy.

Gender:

FEMALE

Ages:

18 years and above

Trial Updated:

07/22/2024

Locations: Greater Baltimore Medical Center, Baltimore, Maryland +6 locations

Conditions: Endometrial Clear Cell Adenocarcinoma, Endometrial Serous Adenocarcinoma, Stage IIIA Uterine Corpus Cancer, Stage IIIB Uterine Corpus Cancer, Stage IIIC Uterine Corpus Cancer, Stage IVA Uterine Corpus Cancer

Learn More ›

Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)

NCT04198766

Recruiting

This is a Phase 1/2, open-label, non-randomized, 4-part trial to determine the safety profile and identify the maximum tolerated dose (MTD) and/or recommended Phase 2 dose (RP2D) of INBRX 106 administered as a single agent or in combination with the anti-PD-1 checkpoint inhibitor (CPI) pembrolizumab (Keytruda®). KEYTRUDA is a registered trademark of Merck Sharp \& Dohme LLC, a subsidiary of Merck \& Co., Inc., Rahway, NJ, USA.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

07/17/2024

Locations: City of Hope, Duarte, California +15 locations

Conditions: Solid Tumor, Non-Small Cell Lung Cancer, Melanoma, Head and Neck Cancer, Gastric Cancer, Renal Cell Carcinoma, Urothelial Carcinoma

Learn More ›

Neoadjuvant Aliya™ PEF Soft Tissue Ablation With Systemic Therapy in Early-Stage Resectable NSCLC

NCT05583188

Terminated

A prospective, single-arm, non-randomized, multi-center, open-label study following patients with resectable stage IIB to IIIA non-small cell lung cancer after Pulsed Electric Fields (PEF) ablation who may be candidates for standard of care neoadjuvant use of checkpoint inhibitor (nivolumab) treatment plus platinum doublet chemotherapy.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

07/17/2024

Locations: Mayo Clinic Rochester, Rochester, Minnesota +2 locations

Conditions: NSCLC

Learn More ›

A Study of BMS-986012 in Combination With Carboplatin, Etoposide, and Nivolumab as First-line Therapy in Extensive-stage Small Cell Lung Cancer

NCT04702880

Active Not Recruiting

The purpose of this study is to demonstrate that treatment with BMS-986012 in combination with carboplatin, etoposide, and nivolumab will have acceptable safety and tolerability and will improve progression-free survival compared with carboplatin, etoposide, and nivolumab alone in newly diagnosed participants with extensive-stage small cell lung cancer (ES-SCLC).

Gender:

ALL

Ages:

18 years and above

Trial Updated:

07/16/2024

Locations: Local Institution - 0075, Birmingham, Alabama +38 locations

Local Institution - 0075, Birmingham, Alabama

Local Institution - 0022, Hackensack, New Jersey

Local Institution - 0002, Durham, North Carolina

Local Institution - 0060, Cincinnati, Ohio

Local Institution, Cincinnati, Ohio

Local Institution - 0067, Cleveland, Ohio

Local Institution - 0081, Nashville, Tennessee

Local Institution, Dallas, Texas

Local Institution - 0003, Westmead, New South Wales

Local Institution - 0023, Greenslopes, Queensland

Local Institution - 0001, Malvern, Victoria

Local Institution - 0004, Murdoch, Western Australia

Local Institution - 0051, Charleroi, Not set

Local Institution - 0034, Gent, Not set

Local Institution - 0050, Liège, Not set

Local Institution - 0012, Edmonton, Alberta

Local Institution - 0064, Brampton, Ontario

Local Institution - 0045, Heraklion, Irakleío

Local Institution - 0036, Athens, Not set

Local Institution - 0038, Athens, Not set

Local Institution - 0030, Peschiera del Garda, Not set

Local Institution - 0031, Pisa, Not set

Local Institution - 0029, Rozzano, Not set

Local Institution - 0073, Sendai, Miyagi

Local Institution - 0070, Osaka-Sayama City, Osaka

Local Institution - 0069, Takatsuki, Osaka

Local Institution - 0077, Ina-machi, Saitama

Local Institution - 0039, Amsterdam, Noord-Holland

Local Institution - 0066, Arnhem, Not set

Local Institution - 0040, Groningen, Not set

Local Institution - 0049, Gdansk, Not set

Local Institution - 0048, Łódź, Not set

Local Institution - 0043, Bucharest, Not set

Local Institution - 0042, Cluj, Not set

Local Institution - 0041, Craiova, Not set

Local Institution - 0007, Barcelona, Barcelona [Barcelona]

Local Institution - 0021, Madrid, Not set

Local Institution - 0005, Majadahonda, Not set

Local Institution - 0006, Málaga, Not set

Conditions: Extensive-stage Small Cell Lung Cancer

Learn More ›

Testing the Use of Targeted Treatment for RET Positive Advanced Non-small Cell Lung Cancer

NCT05364645

Withdrawn

This phase II Lung-MAP treatment trial tests whether carboplatin and pemetrexed with or without selpercatinib works to shrink tumors in patients with RET fusion-positive non-small cell lung cancer that is stage IV or has not responded to previous RET directed therapy. Chemotherapy drugs, such as carboplatin and pemetrexed, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Selpercatinib may st... Read More

Gender:

ALL

Ages:

18 years and above

Trial Updated:

07/05/2024

Locations: NEA Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro, Jonesboro, Arkansas +264 locations

NEA Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro, Jonesboro, Arkansas

University of Arkansas for Medical Sciences, Little Rock, Arkansas

Kaiser Permanente-Anaheim, Anaheim, California

Sutter Auburn Faith Hospital, Auburn, California

Kaiser Permanente-Baldwin Park, Baldwin Park, California

Kaiser Permanente-Bellflower, Bellflower, California

Alta Bates Summit Medical Center-Herrick Campus, Berkeley, California

Kaiser Permanente-Fontana, Fontana, California

Palo Alto Medical Foundation-Fremont, Fremont, California

Kaiser Permanente - Harbor City, Harbor City, California

Kaiser Permanente-Irvine, Irvine, California

Loma Linda University Medical Center, Loma Linda, California

Kaiser Permanente Los Angeles Medical Center, Los Angeles, California

Kaiser Permanente West Los Angeles, Los Angeles, California

Kaiser Permanente-Ontario, Ontario, California

Palo Alto Medical Foundation Health Care, Palo Alto, California

Kaiser Permanente - Panorama City, Panorama City, California

Kaiser Permanente-Riverside, Riverside, California

Sutter Roseville Medical Center, Roseville, California

Sutter Medical Center Sacramento, Sacramento, California

University of California Davis Comprehensive Cancer Center, Sacramento, California

Saint Helena Hospital, Saint Helena, California

Kaiser Permanente-San Diego Zion, San Diego, California

California Pacific Medical Center-Pacific Campus, San Francisco, California

Veterans Affairs Medical Center - San Francisco, San Francisco, California

Kaiser Permanente-San Marcos, San Marcos, California

Palo Alto Medical Foundation-Sunnyvale, Sunnyvale, California

Sutter Solano Medical Center/Cancer Center, Vallejo, California

Presbyterian Intercommunity Hospital, Whittier, California

Kaiser Permanente-Woodland Hills, Woodland Hills, California

Mount Sinai Medical Center, Miami Beach, Florida

Moffitt Cancer Center, Tampa, Florida

Saint Alphonsus Cancer Care Center-Boise, Boise, Idaho

Saint Luke's Cancer Institute - Boise, Boise, Idaho

Saint Alphonsus Cancer Care Center-Caldwell, Caldwell, Idaho

Kootenai Health - Coeur d'Alene, Coeur d'Alene, Idaho

Saint Luke's Cancer Institute - Fruitland, Fruitland, Idaho

Saint Luke's Cancer Institute - Meridian, Meridian, Idaho

Saint Luke's Cancer Institute - Nampa, Nampa, Idaho

Saint Alphonsus Cancer Care Center-Nampa, Nampa, Idaho

Kootenai Clinic Cancer Services - Post Falls, Post Falls, Idaho

Kootenai Cancer Clinic, Sandpoint, Idaho

Saint Luke's Cancer Institute - Twin Falls, Twin Falls, Idaho

Advocate Good Shepherd Hospital, Barrington, Illinois

Illinois CancerCare-Bloomington, Bloomington, Illinois

Illinois CancerCare-Canton, Canton, Illinois

Illinois CancerCare-Carthage, Carthage, Illinois

Centralia Oncology Clinic, Centralia, Illinois

Northwestern University, Chicago, Illinois

Advocate Illinois Masonic Medical Center, Chicago, Illinois

AMG Crystal Lake - Oncology, Crystal Lake, Illinois

Carle on Vermilion, Danville, Illinois

Cancer Care Specialists of Illinois - Decatur, Decatur, Illinois

Decatur Memorial Hospital, Decatur, Illinois

Northwestern Medicine Cancer Center Kishwaukee, DeKalb, Illinois

Illinois CancerCare-Dixon, Dixon, Illinois

Advocate Good Samaritan Hospital, Downers Grove, Illinois

Carle Physician Group-Effingham, Effingham, Illinois

Crossroads Cancer Center, Effingham, Illinois

Advocate Sherman Hospital, Elgin, Illinois

Illinois CancerCare-Eureka, Eureka, Illinois

Illinois CancerCare-Galesburg, Galesburg, Illinois

Northwestern Medicine Cancer Center Delnor, Geneva, Illinois

Advocate South Suburban Hospital, Hazel Crest, Illinois

Illinois CancerCare-Kewanee Clinic, Kewanee, Illinois

Northwestern Medicine Lake Forest Hospital, Lake Forest, Illinois

AMG Libertyville - Oncology, Libertyville, Illinois

Condell Memorial Hospital, Libertyville, Illinois

Illinois CancerCare-Macomb, Macomb, Illinois

Carle Physician Group-Mattoon/Charleston, Mattoon, Illinois

Cancer Care Center of O'Fallon, O'Fallon, Illinois

Advocate Christ Medical Center, Oak Lawn, Illinois

Illinois CancerCare-Ottawa Clinic, Ottawa, Illinois

Advocate Lutheran General Hospital, Park Ridge, Illinois

Illinois CancerCare-Pekin, Pekin, Illinois

Illinois CancerCare-Peoria, Peoria, Illinois

Illinois CancerCare-Peru, Peru, Illinois

Illinois CancerCare-Princeton, Princeton, Illinois

Southern Illinois University School of Medicine, Springfield, Illinois

Springfield Clinic, Springfield, Illinois

Memorial Medical Center, Springfield, Illinois

Carle Cancer Center, Urbana, Illinois

Northwestern Medicine Cancer Center Warrenville, Warrenville, Illinois

Mercy Medical Center - Des Moines, Des Moines, Iowa

HaysMed University of Kansas Health System, Hays, Kansas

University of Kansas Cancer Center, Kansas City, Kansas

Lawrence Memorial Hospital, Lawrence, Kansas

Olathe Health Cancer Center, Olathe, Kansas

University of Kansas Cancer Center-Overland Park, Overland Park, Kansas

Salina Regional Health Center, Salina, Kansas

University of Kansas Health System Saint Francis Campus, Topeka, Kansas

University of Kansas Hospital-Westwood Cancer Center, Westwood, Kansas

University of Kentucky/Markey Cancer Center, Lexington, Kentucky

UPMC Western Maryland, Cumberland, Maryland

Saint Joseph Mercy Hospital, Ann Arbor, Michigan

Bronson Battle Creek, Battle Creek, Michigan

Saint Joseph Mercy Brighton, Brighton, Michigan

Trinity Health IHA Medical Group Hematology Oncology - Brighton, Brighton, Michigan

Saint Joseph Mercy Canton, Canton, Michigan

Trinity Health IHA Medical Group Hematology Oncology - Canton, Canton, Michigan

Saint Joseph Mercy Chelsea, Chelsea, Michigan

Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital, Chelsea, Michigan

Ascension Saint John Hospital, Detroit, Michigan

Great Lakes Cancer Management Specialists-Doctors Park, East China Township, Michigan

Genesee Cancer and Blood Disease Treatment Center, Flint, Michigan

Genesee Hematology Oncology PC, Flint, Michigan

Genesys Hurley Cancer Institute, Flint, Michigan

Hurley Medical Center, Flint, Michigan

Spectrum Health at Butterworth Campus, Grand Rapids, Michigan

Academic Hematology Oncology Specialists, Grosse Pointe Woods, Michigan

Great Lakes Cancer Management Specialists-Van Elslander Cancer Center, Grosse Pointe Woods, Michigan

Bronson Methodist Hospital, Kalamazoo, Michigan

West Michigan Cancer Center, Kalamazoo, Michigan

Sparrow Hospital, Lansing, Michigan

Trinity Health Saint Mary Mercy Livonia Hospital, Livonia, Michigan

Great Lakes Cancer Management Specialists-Macomb Medical Campus, Macomb, Michigan

Trinity Health Muskegon Hospital, Muskegon, Michigan

Cancer and Hematology Centers of Western Michigan - Norton Shores, Norton Shores, Michigan

Spectrum Health Reed City Hospital, Reed City, Michigan

Marie Yeager Cancer Center, Saint Joseph, Michigan

Bhadresh Nayak MD PC-Sterling Heights, Sterling Heights, Michigan

Munson Medical Center, Traverse City, Michigan

Great Lakes Cancer Management Specialists-Macomb Professional Building, Warren, Michigan

Saint John Macomb-Oakland Hospital, Warren, Michigan

Metro Health Hospital, Wyoming, Michigan

Huron Gastroenterology PC, Ypsilanti, Michigan

Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti, Michigan

Sanford Joe Lueken Cancer Center, Bemidji, Minnesota

Essentia Health Saint Joseph's Medical Center, Brainerd, Minnesota

Mercy Hospital, Coon Rapids, Minnesota

Essentia Health - Deer River Clinic, Deer River, Minnesota

Essentia Health Cancer Center, Duluth, Minnesota

Fairview Southdale Hospital, Edina, Minnesota

Essentia Health Hibbing Clinic, Hibbing, Minnesota

Minneapolis VA Medical Center, Minneapolis, Minnesota

Park Nicollet Clinic - Saint Louis Park, Saint Louis Park, Minnesota

Regions Hospital, Saint Paul, Minnesota

United Hospital, Saint Paul, Minnesota

Essentia Health Sandstone, Sandstone, Minnesota

Essentia Health Virginia Clinic, Virginia, Minnesota

Baptist Memorial Hospital and Cancer Center-Golden Triangle, Columbus, Mississippi

Baptist Cancer Center-Grenada, Grenada, Mississippi

Baptist Memorial Hospital and Cancer Center-Union County, New Albany, Mississippi

Baptist Memorial Hospital and Cancer Center-Oxford, Oxford, Mississippi

Baptist Memorial Hospital and Cancer Center-Desoto, Southhaven, Mississippi

Saint Francis Medical Center, Cape Girardeau, Missouri

Parkland Health Center - Farmington, Farmington, Missouri

Truman Medical Centers, Kansas City, Missouri

University of Kansas Cancer Center - North, Kansas City, Missouri

University of Kansas Cancer Center - Lee's Summit, Lee's Summit, Missouri

University of Kansas Cancer Center at North Kansas City Hospital, North Kansas City, Missouri

Missouri Baptist Medical Center, Saint Louis, Missouri

Sainte Genevieve County Memorial Hospital, Sainte Genevieve, Missouri

Missouri Baptist Sullivan Hospital, Sullivan, Missouri

Missouri Baptist Outpatient Center-Sunset Hills, Sunset Hills, Missouri

Community Hospital of Anaconda, Anaconda, Montana

Billings Clinic Cancer Center, Billings, Montana

Bozeman Deaconess Hospital, Bozeman, Montana

Benefis Healthcare- Sletten Cancer Institute, Great Falls, Montana

Kalispell Regional Medical Center, Kalispell, Montana

Community Medical Hospital, Missoula, Montana

OptumCare Cancer Care at Charleston, Las Vegas, Nevada

OptumCare Cancer Care at Fort Apache, Las Vegas, Nevada

New Hampshire Oncology Hematology PA-Concord, Concord, New Hampshire

Solinsky Center for Cancer Care, Manchester, New Hampshire

Virtua Samson Cancer Center, Moorestown, New Jersey

Virtua Voorhees, Voorhees, New Jersey

University of New Mexico Cancer Center, Albuquerque, New Mexico

University of Rochester, Rochester, New York

AdventHealth Infusion Center Asheville, Asheville, North Carolina

AdventHealth Infusion Center Haywood, Clyde, North Carolina

AdventHealth Hendersonville, Hendersonville, North Carolina

AdventHealth Infusion Center Weaverville, Weaverville, North Carolina

Sanford Bismarck Medical Center, Bismarck, North Dakota

Essentia Health Cancer Center-South University Clinic, Fargo, North Dakota

Sanford Broadway Medical Center, Fargo, North Dakota

Sanford Roger Maris Cancer Center, Fargo, North Dakota

Aultman Health Foundation, Canton, Ohio

Miami Valley Hospital South, Centerville, Ohio

Cleveland Clinic Cancer Center/Fairview Hospital, Cleveland, Ohio

Cleveland Clinic Foundation, Cleveland, Ohio

Miami Valley Hospital, Dayton, Ohio

Miami Valley Hospital North, Dayton, Ohio

Atrium Medical Center-Middletown Regional Hospital, Franklin, Ohio

Cleveland Clinic Cancer Center Mansfield, Mansfield, Ohio

Hillcrest Hospital Cancer Center, Mayfield Heights, Ohio

North Coast Cancer Care, Sandusky, Ohio

Trinity's Tony Teramana Cancer Center, Steubenville, Ohio

Cleveland Clinic Cancer Center Strongsville, Strongsville, Ohio

ProMedica Flower Hospital, Sylvania, Ohio

Upper Valley Medical Center, Troy, Ohio

South Pointe Hospital, Warrensville Heights, Ohio

Cleveland Clinic Wooster Family Health and Surgery Center, Wooster, Ohio

Saint Alphonsus Medical Center-Ontario, Ontario, Oregon

Kaiser Permanente Northwest, Portland, Oregon

UPMC Altoona, Altoona, Pennsylvania

UPMC-Heritage Valley Health System Beaver, Beaver, Pennsylvania

UPMC Hillman Cancer Center at Butler Health System, Butler, Pennsylvania

UPMC Camp Hill, Camp Hill, Pennsylvania

Carlisle Regional Cancer Center, Carlisle, Pennsylvania

WellSpan Medical Oncology and Hematology, Chambersburg, Pennsylvania

UPMC Hillman Cancer Center - Passavant - Cranberry, Cranberry Township, Pennsylvania

Ephrata Cancer Center, Ephrata, Pennsylvania

UPMC Hillman Cancer Center Erie, Erie, Pennsylvania

UPMC Cancer Center at UPMC Horizon, Farrell, Pennsylvania

Adams Cancer Center, Gettysburg, Pennsylvania

UPMC Cancer Centers - Arnold Palmer Pavilion, Greensburg, Pennsylvania

Oncology Hematology Associates, Greenville, Pennsylvania

UPMC Pinnacle Cancer Center/Community Osteopathic Campus, Harrisburg, Pennsylvania

IRMC Cancer Center, Indiana, Pennsylvania

UPMC-Johnstown/John P. Murtha Regional Cancer Center, Johnstown, Pennsylvania

Sechler Family Cancer Center, Lebanon, Pennsylvania

UPMC Cancer Center at UPMC McKeesport, McKeesport, Pennsylvania

UPMC Hillman Cancer Center at Rocco And Nancy Ortenzio Cancer Pavilion, Mechanicsburg, Pennsylvania

UPMC Cancer Center - Monroeville, Monroeville, Pennsylvania

UPMC Hillman Cancer Center - Monroeville, Monroeville, Pennsylvania

UPMC Hillman Cancer Center in Coraopolis, Moon, Pennsylvania

Arnold Palmer Cancer Center Medical Oncology Norwin, N. Huntingdon, Pennsylvania

UPMC Cancer Center-Natrona Heights, Natrona Heights, Pennsylvania

UPMC Hillman Cancer Center - New Castle, New Castle, Pennsylvania

UPMC-Saint Margaret, Pittsburgh, Pennsylvania

UPMC-Mercy Hospital, Pittsburgh, Pennsylvania

University of Pittsburgh Cancer Institute (UPCI), Pittsburgh, Pennsylvania

UPMC-Passavant Hospital, Pittsburgh, Pennsylvania

UPMC-Saint Clair Hospital Cancer Center, Pittsburgh, Pennsylvania

UPMC Cancer Center at UPMC Northwest, Seneca, Pennsylvania

UPMC Cancer Center-Uniontown, Uniontown, Pennsylvania

UPMC Uniontown Hospital Radiation Oncology, Uniontown, Pennsylvania

UPMC Washington Hospital Radiation Oncology, Washington, Pennsylvania

UPMC West Mifflin-Cancer Center Jefferson, West Mifflin, Pennsylvania

WellSpan Health-York Cancer Center, York, Pennsylvania

WellSpan Health-York Hospital, York, Pennsylvania

UPMC Memorial, York, Pennsylvania

Prisma Health Cancer Institute - Spartanburg, Boiling Springs, South Carolina

Ralph H Johnson VA Medical Center, Charleston, South Carolina

Medical University of South Carolina, Charleston, South Carolina

Prisma Health Cancer Institute - Easley, Easley, South Carolina

Prisma Health Cancer Institute - Butternut, Greenville, South Carolina

Prisma Health Cancer Institute - Faris, Greenville, South Carolina

Prisma Health Greenville Memorial Hospital, Greenville, South Carolina

Prisma Health Cancer Institute - Eastside, Greenville, South Carolina

Prisma Health Cancer Institute - Greer, Greer, South Carolina

Prisma Health Cancer Institute - Seneca, Seneca, South Carolina

Sanford Cancer Center Oncology Clinic, Sioux Falls, South Dakota

Sanford USD Medical Center - Sioux Falls, Sioux Falls, South Dakota

Baptist Memorial Hospital and Cancer Center-Collierville, Collierville, Tennessee

Baptist Memorial Hospital and Cancer Center-Memphis, Memphis, Tennessee

Duluth Clinic Ashland, Ashland, Wisconsin

Aurora Cancer Care-Southern Lakes VLCC, Burlington, Wisconsin

Aurora Health Care Germantown Health Center, Germantown, Wisconsin

Aurora Cancer Care-Grafton, Grafton, Wisconsin

Aurora BayCare Medical Center, Green Bay, Wisconsin

Aurora Cancer Care-Kenosha South, Kenosha, Wisconsin

Gundersen Lutheran Medical Center, La Crosse, Wisconsin

Aurora Bay Area Medical Group-Marinette, Marinette, Wisconsin

Aurora Cancer Care-Milwaukee, Milwaukee, Wisconsin

Aurora Saint Luke's Medical Center, Milwaukee, Wisconsin

Aurora Sinai Medical Center, Milwaukee, Wisconsin

Vince Lombardi Cancer Clinic - Oshkosh, Oshkosh, Wisconsin

Aurora Cancer Care-Racine, Racine, Wisconsin

Vince Lombardi Cancer Clinic-Sheboygan, Sheboygan, Wisconsin

Aurora Medical Center in Summit, Summit, Wisconsin

Vince Lombardi Cancer Clinic-Two Rivers, Two Rivers, Wisconsin

Aurora Cancer Care-Milwaukee West, Wauwatosa, Wisconsin

Aurora West Allis Medical Center, West Allis, Wisconsin

Conditions: Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8, Stage IVA Lung Cancer AJCC v8, Stage IVB Lung Cancer AJCC v8

Learn More ›

Combination Chemotherapy With or Without Erlotinib Hydrochloride in Treating Patients With Metastatic or Recurrent Squamous Cell Carcinoma of the Head and Neck

NCT01064479

Completed

This randomized phase II trial studies how well combination chemotherapy with or without erlotinib hydrochloride works in treating patients with squamous cell carcinoma of the head and neck that has spread to other parts of the body or has come back. Drugs used in chemotherapy, such as docetaxel, cisplatin, and carboplatin, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Erlotinib hydrochlo... Read More

Gender:

ALL

Ages:

18 years and above

Trial Updated:

07/03/2024

Locations: M D Anderson Cancer Center, Houston, Texas +4 locations

Conditions: Metastatic Squamous Cell Carcinoma of the Hypopharynx, Metastatic Squamous Cell Carcinoma of the Larynx, Metastatic Squamous Cell Carcinoma of the Oral Cavity, Metastatic Squamous Cell Carcinoma of the Oropharynx, Recurrent Hypopharyngeal Squamous Cell Carcinoma, Recurrent Laryngeal Squamous Cell Carcinoma, Recurrent Oral Cavity Squamous Cell Carcinoma, Recurrent Oropharyngeal Squamous Cell Carcinoma, Stage IV Hypopharyngeal Squamous Cell Carcinoma AJCC v7, Stage IV Laryngeal Squamous Cell Carcinoma AJCC v7, Stage IV Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7, Stage IV Oropharyngeal Squamous Cell Carcinoma AJCC v7, Stage IVA Hypopharyngeal Squamous Cell Carcinoma AJCC v7, Stage IVA Laryngeal Squamous Cell Carcinoma AJCC v7, Stage IVA Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7, Stage IVA Oropharyngeal Squamous Cell Carcinoma AJCC v7, Stage IVB Hypopharyngeal Squamous Cell Carcinoma AJCC v7, Stage IVB Laryngeal Squamous Cell Carcinoma AJCC v7, Stage IVB Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7, Stage IVB Oropharyngeal Squamous Cell Carcinoma AJCC v7, Stage IVC Hypopharyngeal Squamous Cell Carcinoma AJCC v7, Stage IVC Laryngeal Squamous Cell Carcinoma AJCC v7, Stage IVC Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7, Stage IVC Oropharyngeal Squamous Cell Carcinoma AJCC v7

Learn More ›

Browse by State

Carboplatin treatment options in Alabama

Carboplatin treatment options in Alaska

Carboplatin treatment options in Arizona

Carboplatin treatment options in Arkansas

Carboplatin treatment options in California

Carboplatin treatment options in Colorado

Carboplatin treatment options in Connecticut

Carboplatin treatment options in Delaware

Carboplatin treatment options in District of Columbia

Carboplatin treatment options in Florida

Carboplatin treatment options in Georgia

Carboplatin treatment options in Hawaii

Carboplatin treatment options in Idaho

Carboplatin treatment options in Illinois

Carboplatin treatment options in Indiana

Carboplatin treatment options in Iowa

Carboplatin treatment options in Kansas

Carboplatin treatment options in Kentucky

Carboplatin treatment options in Louisiana

Carboplatin treatment options in Maine

Carboplatin treatment options in Montana

Carboplatin treatment options in Nebraska

Carboplatin treatment options in Nevada

Carboplatin treatment options in New Hampshire

Carboplatin treatment options in New Jersey

Carboplatin treatment options in New Mexico

Carboplatin treatment options in New York

Carboplatin treatment options in North Carolina

Carboplatin treatment options in North Dakota

Carboplatin treatment options in Ohio

Carboplatin treatment options in Oklahoma

Carboplatin treatment options in Oregon

Carboplatin treatment options in Maryland

Carboplatin treatment options in Massachusetts

Carboplatin treatment options in Michigan

Carboplatin treatment options in Minnesota

Carboplatin treatment options in Mississippi

Carboplatin treatment options in Missouri

Carboplatin treatment options in Pennsylvania

Carboplatin treatment options in Rhode Island

Carboplatin treatment options in South Carolina

Carboplatin treatment options in South Dakota

Carboplatin treatment options in Tennessee

Carboplatin treatment options in Texas

Carboplatin treatment options in Utah

Carboplatin treatment options in Vermont

Carboplatin treatment options in Virginia

Carboplatin treatment options in Washington

Carboplatin treatment options in West Virginia

Carboplatin treatment options in Wisconsin

Carboplatin treatment options in Wyoming